Claes‐Håkan Bergh

1.2k total citations
22 papers, 878 citations indexed

About

Claes‐Håkan Bergh is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Claes‐Håkan Bergh has authored 22 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Claes‐Håkan Bergh's work include Cardiovascular Function and Risk Factors (7 papers), Cardiac pacing and defibrillation studies (6 papers) and Heart Failure Treatment and Management (5 papers). Claes‐Håkan Bergh is often cited by papers focused on Cardiovascular Function and Risk Factors (7 papers), Cardiac pacing and defibrillation studies (6 papers) and Heart Failure Treatment and Management (5 papers). Claes‐Håkan Bergh collaborates with scholars based in Sweden, France and Norway. Claes‐Håkan Bergh's co-authors include Bert Andersson, Åsa Haraldsson, Sven-Erik Ricksten, N. Kieler‐Jensen, Paul Mohaçsi, Michel Komajda, Bengt Rundqvist, Kenneth Dickstein, Tiny Jaarsma and Marco Metra and has published in prestigious journals such as Journal of the American College of Cardiology, CHEST Journal and Transplantation.

In The Last Decade

Claes‐Håkan Bergh

22 papers receiving 846 citations

Peers

Claes‐Håkan Bergh
Davis Drinkwater United States
Terry L. Flanagan United States
G. Marrone United States
Peter E. Frasco United States
R Gourgon France
Rebecca Quigg United States
Martin Allard United States
Aurora M. Morariu Netherlands
Davis Drinkwater United States
Claes‐Håkan Bergh
Citations per year, relative to Claes‐Håkan Bergh Claes‐Håkan Bergh (= 1×) peers Davis Drinkwater

Countries citing papers authored by Claes‐Håkan Bergh

Since Specialization
Citations

This map shows the geographic impact of Claes‐Håkan Bergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes‐Håkan Bergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes‐Håkan Bergh more than expected).

Fields of papers citing papers by Claes‐Håkan Bergh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claes‐Håkan Bergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes‐Håkan Bergh. The network helps show where Claes‐Håkan Bergh may publish in the future.

Co-authorship network of co-authors of Claes‐Håkan Bergh

This figure shows the co-authorship network connecting the top 25 collaborators of Claes‐Håkan Bergh. A scholar is included among the top collaborators of Claes‐Håkan Bergh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claes‐Håkan Bergh. Claes‐Håkan Bergh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bergh, Claes‐Håkan, Bert Andersson, Ulf Dahlström, et al.. (2010). Intravenous Levosimendan vs. Dobutamine in Acute Decompensated Heart Failure Patients on Beta-Blockers. European Journal of Heart Failure. 12(4). 404–410. 57 indexed citations
2.
Gullestad, Lars, Martin Iversen, Svend-Aage Mortensen, et al.. (2010). Everolimus With Reduced Calcineurin Inhibitor in Thoracic Transplant Recipients With Renal Dysfunction: A Multicenter, Randomized Trial. Transplantation. 89(7). 864–872. 114 indexed citations
3.
Gilljam, Thomas & Claes‐Håkan Bergh. (2009). Right Ventricular Cardiomyopathy: Timing of Heart Transplantation in Uhl’s Anomaly and Arrythmogenic Right Ventricular Cardiomyopathy. European Journal of Heart Failure. 11(1). 106–109. 9 indexed citations
4.
Selimović, Nedim, et al.. (2009). Endothelin-1 Across the Lung Circulation in Patients With Pulmonary Arterial Hypertension and Influence of Epoprostenol Infusion. The Journal of Heart and Lung Transplantation. 28(8). 808–814. 3 indexed citations
5.
Selimović, Nedim, Bert Andersson, Claes‐Håkan Bergh, et al.. (2008). Pulmonary hemodynamics as predictors of mortality in patients awaiting lung transplantation. Transplant International. 21(4). 314–319. 18 indexed citations
6.
Metra, Marco, Dirk L. Brutsaert, Kenneth Dickstein, et al.. (2007). Treatment of Advanced Chronic Heart Failure with Normal Left Ventricular Ejection Fraction. Response to the letter by Dr. Martinez-Selles. European Journal of Heart Failure. 9(12). 1224–1225. 1 indexed citations
7.
Lidén, Hans, Kristjan Karason, Claes‐Håkan Bergh, et al.. (2007). The Feasibility of Left Ventricular Mechanical Support as a Bridge to Cardiac Recovery. European Journal of Heart Failure. 9(5). 525–530. 47 indexed citations
8.
Metra, Marco, Piotr Ponikowski, Kenneth Dickstein, et al.. (2007). Advanced Chronic Heart Failure: A Position Statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 9(6-7). 684–694. 269 indexed citations
9.
Selimović, Nedim, et al.. (2007). Assessment of Pulmonary Vascular Resistance by Doppler Echocardiography in Patients With Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation. 26(9). 927–934. 60 indexed citations
10.
Mobini, Reza, Michael Fu, Per‐Anders Jansson, et al.. (2006). Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine. Clinical Science. 110(3). 329–336. 15 indexed citations
11.
Bergh, Claes‐Håkan, Kenneth Caidahl, Robert Eggertsen, et al.. (2004). Can brain natriuretic peptide (BNP) be used as a screening tool in general practice?. Scandinavian Journal of Primary Health Care. 22(3). 187–190. 2 indexed citations
12.
Bollano, Entela, Claes‐Håkan Bergh, Elmir Ömerovic, et al.. (2001). Growth Hormone Alone or Combined with Metoprolol Preserves Cardiac Function After Myocardial Infarction in Rats. European Journal of Heart Failure. 3(6). 651–660. 8 indexed citations
13.
Mohaçsi, Paul, Mario C. Deng, Claes‐Håkan Bergh, et al.. (2000). Implantable Left Ventricular Assist Systems (LVAS): Recent Results. A Report from a Series of Meetings Sponsored by the Study Group on Advanced Heart Failure of the Working Group on Heart Failure. European Journal of Heart Failure. 2(1). 13–18. 6 indexed citations
14.
Swedberg, Karl, Claes‐Håkan Bergh, Kenneth Dickstein, J. L. McNay, & Martin H. Steinberg. (2000). The effects of moxonidine, a novel imidazoline, on plasma norepinephrine in patients with congestive heart failure. Journal of the American College of Cardiology. 35(2). 398–404. 41 indexed citations
15.
Selimović, Nedim, et al.. (2000). Fatal Dilated Cardiomyopathy Associated with a Mitochondrial DNA Deletion. Cardiology. 94(1). 68–71. 13 indexed citations
16.
Kjellman, Ulf, Per Hallgren, Claes‐Håkan Bergh, et al.. (2000). Weaning from mechanical support in a patient with acute heart failure and multiple sclerosis. The Annals of Thoracic Surgery. 69(2). 628–630. 10 indexed citations
17.
Isgaard, Jörgen & Claes‐Håkan Bergh. (1999). Clinical Potential of Growth Hormone in the Treatment of Congestive Heart Failure. BioDrugs. 12(4). 245–250. 3 indexed citations
19.
Eliasson, Tore, Clas Mannheimer, Finn Waagstein, et al.. (1998). Myocardial Turnover of Endogenous Opioids and Calcitonin-Gene-Related Peptide in the Human Heart and the Effects of Spinal Cord Stimulation on Pacing-Induced Angina Pectoris. Cardiology. 89(3). 170–177. 59 indexed citations
20.
Bergh, Claes‐Håkan, et al.. (1994). Diabetes‐Induced Changes in the Gi‐Modulated Muscarinic Receptor‐Adenylyl Cyclase System in Rat Myocardium*. Pharmacology & Toxicology. 75(3-4). 186–193. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026